Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$0.77 USD
+0.01 (1.57%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $0.79 +0.02 (2.07%) 7:56 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Predictive Oncology Inc. has a market cap of $7.79M, which represents its share price of $0.76 multiplied by its outstanding shares number of 10.22M. As a small-cap company, POAI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
POAI 0.77 +0.01(1.57%)
Will POAI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for POAI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for POAI
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
POAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates
American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates
Other News for POAI
Predictive Oncology (POAI) Announces Stock Offering by Existing Holders
Predictive Oncology files to sell 1.92M shares of common stock for holders
Predictive Oncology (POAI) Announces Plan to Offer 1.92M Shares | POAI Stock News
Predictive Oncology files to sell 1.92M shares of common stock for holders
Predictive Oncology (POAI) Expands ChemoFx and Boosts Growth Prospects | POAI Stock News